Fermented Vegetables as a Potential Treatment for Irritable Bowel Syndrome

被引:2
作者
Garnas, Eirik
机构
[1] Independent researcher, Oslo
关键词
fermented food; probiotics; irritable bowel syndrome; IBS; sauerkraut; kimchi; microbiome; gut health; LACTIC-ACID BACTERIA; GUT-MICROBIOTA; PALEOLITHIC NUTRITION; INFLAMMATION; DYSBIOSIS; BALANCE; HEALTH; FIBER; DIET;
D O I
10.1016/j.cdnut.2023.100039
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Foods and supplements containing microorganisms with expected beneficial effects are increasingly investigated and utilized in the treatment of human illness, including irritable bowel syndrome (IBS). Research points to a prominent role of gut dysbiosis in the multiple aberrations in gastrointestinal function, immune balance, and mental health seen in IBS. The proposition of the current Perspective is that fermented vegetable foods, in combination with a healthy and stable diet, may be particularly useful for addressing these disturbances. This is based on the recognition that plants and their associated microorganisms have contributed to shaping human microbiota and adaptation over evolutionary time. In particular, lactic acid bacteria with immunomodulatory, antipathogenic, and digestive properties are prevalent in products such as sauerkraut and kimchi. Additionally, by adjusting the salt content and fermentation time, products with a microbial and therapeutic potential beyond that of regular ferments could potentially be produced. Although more clinical data are required to make firm assertions, the low-risk profile, combined with biological considerations and reasoning and considerable circumstantial and anecdotal evidence, indicate that fermented vegetables are worthy of consideration by health professionals and patients dealing with IBS-related issues. To maximize microbial diversity and limit the risk of adverse effects, small doses of multiple products, containing different combinations of traditionally fermented vegetables and/or fruits, is suggested for experimental research and care.
引用
收藏
页数:7
相关论文
共 50 条
[21]   Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan [J].
Hamazaki, Motonobu ;
Sawada, Tsunaki ;
Yamamura, Takeshi ;
Maeda, Keiko ;
Mizutani, Yasuyuki ;
Ishikawa, Eri ;
Furune, Satoshi ;
Yamamoto, Kenta ;
Ishikawa, Takuya ;
Kakushima, Naomi ;
Furukawa, Kazuhiro ;
Ohno, Eizaburo ;
Honda, Takashi ;
Kawashima, Hiroki ;
Ishigami, Masatoshi ;
Nakamura, Masanao ;
Fujishiro, Mitsuhiro .
BMC GASTROENTEROLOGY, 2022, 22 (01)
[22]   Impact of Enteric Nervous Cells on Irritable Bowel Syndrome: Potential Treatment Options [J].
Pastras, Ploutarchos ;
Aggeletopoulou, Ioanna ;
Triantos, Christos .
MICROORGANISMS, 2024, 12 (10)
[23]   Probiotics in Irritable Bowel Syndrome The Science and the Evidence [J].
Quigley, Eamonn M. M. .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, 49 :S60-S64
[24]   Treatment of irritable bowel syndrome [J].
Basnayake, Chamara .
AUSTRALIAN PRESCRIBER, 2018, 41 (05) :145-149
[25]   Application of metabolomics to the study of irritable bowel syndrome [J].
Bennet, Sean M. ;
Keshteli, Ammar H. ;
Bercik, Premysl ;
Madsen, Karen L. ;
Reed, David ;
Vanner, Stephen J. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2020, 32 (06)
[26]   Profile of rifaximin and its potential in the treatment of irritable bowel syndrome [J].
Iorio, Natalya ;
Malik, Zubair ;
Schey, Ron .
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2015, 8 :159-166
[27]   Treatment of irritable bowel syndrome [J].
Robin C. Spiller .
Current Treatment Options in Gastroenterology, 2003, 6 (4) :329-337
[28]   Probiotics in irritable bowel syndrome: Where are we? [J].
Barbara, Giovanni ;
Cremon, Cesare ;
Azpiroz, Fernando .
NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 30 (12)
[29]   The role of fiber in the treatment of irritable bowel syndrome - Therapeutic recommendations [J].
Zuckerman, MJ .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (02) :104-108
[30]   Selective Serotonin Reuptake Inhibitors for the Treatment of Irritable Bowel Syndrome [J].
Bundeff, Andrew W. ;
Woodis, C. Brock .
ANNALS OF PHARMACOTHERAPY, 2014, 48 (06) :777-784